Citation Tools
PDFRegular and Young Investigator Award Abstracts
Combination Immunotherapies
850 Interim results for phase 1b dose expansion of MTL-CEBPA in combination with pembrolizumab in patients with advanced solid tumour malignancies
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 850 Interim results for phase 1b dose expansion of MTL-CEBPA in combination with pembrolizumab in patients with advanced solid tumour malignancies